ArticleJournal of food science2025
Assessment of Microencapsulated and Free Form Presumptive Probiotics in Fermented Black Carrot Juice (Shalgam) Production.
Article in Journal of food science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
There is no standardized production or regulation for making fermented black carrot juice (shalgam). This study was conducted to address the lack of standardized method and commercially available starter cultures for shalgam production. The present study investigated the use of shalgam-derived presumptive probiotics (Lacticaseibacillus paracasei NL1, Pediococcus acidilactici AL9, and Pichia kudriavzevii NM3) as starter cultures in the production of shalgam to improve its usefulness by transforming it into a high value-added product and enriching its presumptive probiotic content. In this context, free and microencapsulated presumptive probiotics were incorporated into the juice prior to the fermentation. The pH value, total acidity, and lactic acid bacteria and yeast counts of the samples were evaluated during fermentation. The use of presumptive probiotic cultures in the free form reduced the fermentation period from 8 to 6 days. Shalgam comprising the free (7.35-8.32 log CFU/mL) and microencapsulated (6.97-8.34 log CFU/g) probiotics maintained the desired cell counts during storage at 4°C for 90 days. Microencapsulation exerted a protective effect on the strains. At the end of storage, the highest phenolic contents were observed in the samples containing L. paracasei NL1 in the free (3415.75 mg GAE/L) or microencapsulated (3598.00 mg GAE/L) form, whereas the samples containing AL9 and NL1 free cells demonstrated the highest 1,1-diphenyl-2-picrylhydrazyl radical values of 78.30% and 77.81%, respectively. Consequently, the strains demonstrate considerable potential for application in the production of shalgam possessing probiotic properties by improving the bioactivity and sensory properties of the product.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.